Insider · CIK 0001916553
Marinus Verwijs
Files at JBIO (Aerovate Therapeutics, Inc.). First filing Nov 3, 2023, latest Jun 14, 2024.
In brief
Marinus Verwijs files SEC Form 4 as officer at JBIO (Aerovate Therapeutics, Inc.). Since Nov 3, 2023, Marinus Verwijs has reported 0 open-market buys worth $0 and 5 open-market sells worth $610k, the latest filed on Jun 14, 2024.
A track record needs three past buys with six months of prices behind them; Marinus Verwijs has 0, so none is measured yet.
The newest scored trade: sold $265k of JBIO on Jun 14, 2024, filed Jun 14, 2024, scored 28 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
JBIO: Aerovate Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | Aerovate Therapeutics, Inc. | $265k 10,600 shares | -100% | +157% from low-20% from high | |
| 49Moderate | Aerovate Therapeutics, Inc. | $42k 1,981 shares | -100% | +117% from low-33% from high | |
| 26Weak | Aerovate Therapeutics, Inc. | $155k 5,300 shares | -100% | +221% from low0% from high | |
| 26Weak | Aerovate Therapeutics, Inc. | $138k 5,300 shares | -100% | +168% from low-5% from high | |
| 43Moderate | Aerovate Therapeutics, Inc. | $10k 970 shares | -100% | +11% from low-65% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 14, 2024 | JBIO AEROVATE THERAPEUTICS, INC. | 10,600 0.04% of outstanding | $265k | Jun 14, 2024 | $335k |
| May 2, 2024 | JBIO Aerovate Therapeutics, Inc. | 1,981 0.01% of outstanding | $42k | May 2, 2024 | $293k |
| Apr 1, 2024 | JBIO AEROVATE THERAPEUTICS, INC. | 5,300 0.02% of outstanding | $155k | Apr 1, 2024 | $138k |
| Mar 19, 2024 | JBIO AEROVATE THERAPEUTICS, INC. | 5,300 0.02% of outstanding | $138k | Mar 19, 2024 | none |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,600 | $14.59 | $155k | 10,600 | Jun 14, 2024 |
| Jun 14, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10,600 | $25.00 | $265k | 0 | Jun 14, 2024 |
| Jun 14, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,600 | $0.00 | $0 | 68,800 | Jun 14, 2024 |
| May 2, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock | -1,981 | $21.02 | $42k | 0 | May 3, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,300 | $14.59 | $77k | 5,300 | Apr 3, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,796 | $28.87 | $110k | 1,504 | Apr 3, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,504 | $30.00 | $45k | 0 | Apr 3, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,300 | $0.00 | $0 | 79,400 | Apr 3, 2024 |
| Mar 19, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,300 | $14.59 | $77k | 5,300 | Mar 20, 2024 |
| Mar 19, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,536 | $25.68 | $65k | 2,764 | Mar 20, 2024 |
| Mar 19, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,764 | $26.46 | $73k | 0 | Mar 20, 2024 |
| Mar 19, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,300 | $0.00 | $0 | 84,700 | Mar 20, 2024 |
| Jan 22, 2024 | JBIO Aerovate Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +66,586 | $0.00 | $0 | 66,586 | Jan 24, 2024 |
| Nov 1, 2023 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock | -970 | $10.46 | $10k | 0 | Nov 3, 2023 |
Questions about Marinus Verwijs
Answered from the filings on this page, as of the latest one.
Is Marinus Verwijs buying or selling?
Not in the last 12 months. Marinus Verwijs's latest open-market trade on SEC Form 4 was sold $265k of JBIO on Jun 14, 2024.
How did Marinus Verwijs's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marinus Verwijs has 0.
Where does Marinus Verwijs file Form 4?
Marinus Verwijs has filed Form 4 at JBIO (Aerovate Therapeutics, Inc.) as CHIEF TECHNICAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.